Table of Content - Acute Otitis Media Treatment Market

Acute otitis media (AOM) is inflammation of the fluid in the middle ear. AOM is the most common infection and mainly caused in children under the age of 7 years. According to an article published American Family Physician Journal in 2013, around 80% of children will have at least one episode of acute otitis media (AOM) before their school age. AOM is mainly caused by bacteria such as Streptococcus pneumoniae (strep) and Hemophilus influenzae (H. flu) and viruses. Bacteria account for 85% cases of AOM and viruses account for only 15%. AOM is mostly treated with antibiotics usually for 7–10 days and with some analgesic and anesthetic in order to the reduce pain.

Market Dynamics

Increasing prevalence of acute otitis media is expected to be a major driver for growth of the market. Acute otitis media is a very common disease and occurs mostly in children, therefore, increasing prevalence of this disease is expected to increase demand for treatment drugs, thereby positively affecting market growth. According to an article published in The Journal of Laryngology & Otology, in 2013, prevalence of otitis media subtypes is between 7.1–12.8%. Furthermore, recent launches and FDA approvals for new drugs for the treatment of acute otitis media is also expected to drive the market growth in the near future. For instance, in 2015, Otonomy, Inc. received U.S. Food and Drug Administration (FDA) approval for its OTIPRIO (ciprofloxacin otic suspension) indicated for the treatment of pediatric patients with bilateral otitis media with effusion undergoing tympanostomy tube placement. In 2016, Otonomy, Inc. launched OTIPRIO in U.S. market.

Key features of the study

This report provides in-depth analysis of acute otitis media treatment market and provides market size (USD Mn) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2026–2033), considering 2025 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global acute otitis media treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories, GlaxoSmithKline plc., Bayer AG, Novartis AG, Pediapharm Inc., Sanofi S.A., and Bristol Myers Squibb Company.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global acute otitis media treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the acute otitis media treatment market

Market Segmentation

By Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
- Antibiotics
- Nonsteroidal anti-Inflammatory drug
- Analgesic
- Anaesthetic
By Formulation Insights (Revenue, USD Mn, 2021 - 2033)
- Oral
- Topical
By Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Retail pharmacies
- Online pharmacies
By Region Insights (Revenue, USD Mn, 2021 - 2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - North Africa
  - Central Africa
Key Players
- Pfizer, Inc.
- Eli Lilly and Company
- Abbott Laboratories
- GlaxoSmithKline plc.
- Bayer AG
- Novartis AG
- Pediapharm Inc.
- Sanofi S.A.
- Bristol Myers Squibb Company

Table of Contents

Research Objective and assumption

Research Objectives
Assumptions
Abbreviations

Market Purview

Report Description

Market Definition and Scope

Executive Summary

Market Snippet, By Drug Type
Market Snippet, By Formulation
Market Snippet, By Distribution Channel
Market Snippet, By Region

Coherent Opportunity Map (COM)

Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
Market Opportunities

Impact Analysis
Technological Trends
Unmet Needs
Regulatory Scenario
Recent Product Approvals/Launch
Technological Advancement
PEST Analysis
Porter’s Five Forces Analysis

Global Acute Otitis Media Treatment Market, By Drug Type, 2021–2033 (USD Mn)

Introduction

Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends

Antibiotics

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)

Nonsteroidal anti-Inflammatory drug

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)

Analgesic

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)

Anaesthetic

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)

Global Acute Otitis Media Treatment Market, By Formulation, 2021–2033 (USD Mn)

Introduction

Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends

Oral

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)

Topical

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)

Global Acute Otitis Media Treatment Market, By Distribution Channel, 2021–2033 (USD Mn)

Introduction

Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends

Hospital

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)

Retail pharmacies

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)

Online pharmacies

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)

Global Acute Otitis Media Treatment Market, By Region, 2021–2033 (USD Mn)

Introduction

Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033

North America

Market Size and Forecast, By Drug Type, 2021–2033 (USD Mn)
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country, 2021–2033 (USD Mn)

U.S.
Canada

Europe

Market Size and Forecast, By Drug Type, 2021–2033 (USD Mn)
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country, 2021–2033 (USD Mn)

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

Market Size and Forecast, By Drug Type, 2021–2033 (USD Mn)
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country, 2021–2033 (USD Mn)

China
India
Japan
ASEAN
Australia
South Korea
Rest of APAC

Latin America

Market Size and Forecast, By Drug Type, 2021–2033 (USD Mn)
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country, 2021–2033 (USD Mn)

Brazil
Mexico
Argentina
Rest of Latin America

Africa

Market Size and Forecast, By Drug Type, 2021–2033 (USD Mn)
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country, 2021–2033 (USD Mn)

Central Africa
South Africa
North Africa

Middle East

Market Size and Forecast, By Drug Type, 2021–2033 (USD Mn)
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country, 2021–2033 (USD Mn)

GCC
Israel
Rest of Middle East

Competitive Landscape

Heat Map Analysis
Company Profiles

Pfizer, Inc.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Eli Lilly and Company

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Abbott Laboratories

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

GlaxoSmithKline plc.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Bayer AG

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Novartis AG

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Pediapharm Inc.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Sanofi S.A.

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Bristol Myers Squibb Company

Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies

Section

References
Research Methodology
About us and Sales Contact

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE